NEOG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Neogen Corp (NEOG) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's financial performance is weak, with significant YoY declines in revenue, net income, and EPS. While hedge funds are showing interest and analysts have raised price targets, the technical indicators and lack of recent positive news do not support a compelling entry point. The options data suggests a bullish sentiment, but the overall picture does not align with the user's investment goals.
The MACD is negative and contracting (-0.051), RSI is neutral at 48.852, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level (8.942) with resistance at 9.469 and support at 8.415. Overall, the technical indicators do not signal a strong buy.
Hedge funds have significantly increased their buying activity (up 999.08% last quarter). Analysts have raised the price target to $12 and maintained a Buy rating, citing improved portfolio performance and cost actions.
The company's financial performance in Q2 2026 is weak, with revenue, net income, and EPS all showing significant YoY declines. No recent news or congress trading data is available to suggest any immediate positive catalysts.
In Q2 2026, revenue dropped by -2.84% YoY to $224.69M, net income fell by -96.51% YoY to -$15.92M, and EPS declined by -96.67% YoY to -$0.07. Gross margin also decreased to 37.29%, down -3.89% YoY.
Guggenheim raised the price target to $12 from $8 and maintained a Buy rating, citing improved portfolio performance and cost actions. However, they caution that one quarter does not establish a trend.
